Management of acute renal failure due to marked hyperuricemia.
D058186:Acute Kidney Injury / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy*; D000293:Adolescent; D000493:Allopurinol / Q000008:administration & dosage / Q000627:therapeutic use*; D001639:Bicarbonates / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D007668:Kidney / Q000098:blood supply; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D012039:Regional Blood Flow; D006435:Renal Dialysis; D012964:Sodium; D013921:Thrombocytopenia / Q000150:complications; D014527:Uric Acid / Q000097:blood*; D014750:Vincristine / Q000009:adverse effects
D001639:Bicarbonates; D014527:Uric Acid; D014750:Vincristine; D000493:Allopurinol; D012964:Sodium; D011188:Potassium; D011241:Prednisone; D008727:Methotrexate